Crew Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Crew Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$974K	Buy	+16,907	New	+$971K	0.53%	54
2024 Q1	–	Sell	-5,195	Closed	-$267K	–	121
2023 Q4	$267K	Sell	5,195 -396	-7%	-$20.8K	0.27%	69
2023 Q3	$325K	Sell	5,591 -1,672	-23%	-$102K	0.35%	55
2023 Q2	$464K	Sell	7,263 -1,870	-20%	-$125K	0.53%	41
2023 Q1	$633K	Sell	9,133 -700	-7%	-$49.4K	0.91%	31
2022 Q4	$707K	Sell	9,833 -450	-4%	-$33.9K	1.02%	26
2022 Q3	$731K	Sell	10,283 -250	-2%	-$18.1K	1%	24
2022 Q2	$811K	Sell	10,533 -150	-1%	-$11.4K	1.02%	24
2022 Q1	$780K	Sell	10,683 -200	-2%	-$13.4K	0.75%	35
2021 Q4	$679K	Sell	10,883 -800	-7%	-$46.9K	0.57%	39
2021 Q3	$691K	Sell	11,683 -250	-2%	-$16.5K	0.64%	37
2021 Q2	$797K	Sell	11,933 -100	-0.8%	-$6.52K	0.74%	37
2021 Q1	$760K	Buy	+12,033	New	+$749K	0.76%	39

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Crew Capital Management's BMY Position: Q2 2026 in Review

Crew Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 16,907 shares worth $974K. The stake represents 0.53% of the portfolio and ranks #54 among its holdings. This is a return to the name: Crew Capital Management previously reported a position in BMY as recently as Q4 2023.

Crew Capital Management first reported a position in BMY in Q1 2021 and has held it in 13 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Crew Capital Management held 16,907 shares of Bristol-Myers Squibb worth $974K as of Q2 2026.
Bristol-Myers Squibb was a new Crew Capital Management position in Q2 2026.
Bristol-Myers Squibb made up 0.53% of Crew Capital Management's portfolio in Q2 2026, its #54 holding.
Crew Capital Management first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 13 quarters since.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Crew Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.